News Novartis drug effective in advanced MS Siponimod slowed disability progression in secondary progressive multiple sclerosis
News Scangos to leave Biogen at a crossroads Company has grown, but direction towards next stage is unclear
US FDA fast-tracks review of Roche's potential MS blockbuster Regulator to make decision by year end.
News Merck KGaA acquires MS brain training software provider Merck KGaA will now integrate the technology into its MSdialog platform.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
